FDA Associate Commissioners Transition As PDUFA IV Rolls Over To V
This article was originally published in The Pink Sheet Daily
Executive Summary
Peter Lurie will replace David Dorsey as Acting Associate Commissioner for Policy and Planning, and Melinda Plaisier becomes Acting Associate Commissioner for Regulatory Affairs as Dara Corrigan moves to FDA’s European office.
You may also be interested in...
Leader Of US FDA's EU Mutual Recognition Effort Departs For Industry
Dara Corrigan will become Fresenius-Kabi’s VP for global affairs and policy.
CDER’s New Compliance Director Sklamberg Brings Experience On Compounding Issues
Howard Sklamberg, deputy associate commissioner in FDA’s Office of Regulatory Affairs, will take over as director of the Center for Drug Evaluation and Research’s Compliance Office in January; acting compliance director Ilisa Bernstein will resume her role as deputy director.
FDA Office of Regulatory Affairs Make-Over Blends Domestic, International Work
The reorganized ORA has eight new offices to better handle new legislative authorities and globalization of its regulated products; FDA expects to increase partnerships with other government officials and foreign entities.